Authors: Le, XF Marcelli, M McWatters, A Nan, BC Mills, GB O'Brian, CA Bast, RC

Citation: Xf. Le et al., Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activity, ONCOGENE, 20(57), 2001, pp. 8258-8269

Authors: Le, XF McWatters, A Wiener, J Wu, JY Mills, GB Bast, RC

Citation: Xf. Le et al., Anti-HER2 antibody and heregulin suppress growth of HER2-overexpressing human breast cancer cells through different mechanisms, CLIN CANC R, 6(1), 2000, pp. 260-270

Authors: Bast, RC Yu, Y Xu, FJ Le, XF Mills, GB

Citation: Rc. Bast et al., Molecular approaches to management of epithelial ovarian cancer, INT J GYN C, 10, 2000, pp. 2-7

Authors: Le, XF Vadlamudi, R McWatters, A Bae, DS Mills, GB Kumar, R Bast, RC

Citation: Xf. Le et al., Differential signaling by an anti-p185(HER2) antibody and heregulin, CANCER RES, 60(13), 2000, pp. 3522-3531

Authors: Xu, FJ Yu, YH Le, XF Boyer, C Mills, GB Bast, RC

Citation: Fj. Xu et al., The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expression, CLIN CANC R, 5(11), 1999, pp. 3653-3660

Authors: Le, XF Groner, Y Kornblau, SM Gu, Y Hittelman, WN Levanon, D Mehta, K Arlinghaus, RB Chang, KS

Citation: Xf. Le et al., Regulation of AML2/CBFA3 in hematopoietic cells through the retinoic acid receptor alpha-dependent signaling pathway, J BIOL CHEM, 274(31), 1999, pp. 21651-21658